Clinical Trials in Salt Lake City

Showing 12461-12480 of 16,694 trials

Maternal Immunization: Giving Immunity For Tomorrow

NCT01496079

Study objectives are to compare * influenza antibody levels in infant sera and maternal colostrum or breast milk at delivery, 2, and 6 months women who receive influenza immunization in early pregnancy, late pregnancy, or no influenza immunization during pregnancy and their infants Study hypotheses are that infants born to pregnant women who receive influenza immunization in late pregnancy will have * higher levels and a longer serum influenza antibody duration in sera (hemagglutination inhibition (HAI) titers) and colostrum/breast milk (influenza-specific IgA and IgG by enzyme-linked immunosorbent assay (ELISA) than infants of women immunized in early pregnancy or not immunized

PregnancyInfluenza

University of Utah166 participantsStarted Dec 2011

Salt Lake City, Utah, United States

COMPLETEDNA< 1 mile

Immunization Protection in Child Care (IPiCC) Project

NCT01773759

Ensuring that all children are fully immunized against vaccine-preventable diseases is a critical public health issue. Child care programs are critical targets for efforts to increase the proportion of infants and young children who are fully immunized. The primary objective of this proposal is to rigorously examine current state, local government, and child care providers' efforts and barriers to ensuring that all enrolled children are up-to-date for required immunizations and to evaluate strategies to improve immunization coverage in child care programs.

Up-to-date Immunization Status for Children in Child Care

University of Utah107 participantsStarted Sep 2011

Salt Lake City, Utah, United States

COMPLETEDPhase 2< 1 mile

Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant

NCT00343785

This clinical trial is studying how well giving cyclophosphamide together with anti-thymocyte globulin followed by methotrexate and cyclosporine works in preventing chronic graft-vs-host disease (GVHD) in patients with severe aplastic anemia undergoing donor bone marrow transplant. Giving low doses of chemotherapy, such as cyclophosphamide, before a donor bone marrow transplant helps stop the growth of abnormal cells. It also stops the patient's immune system from rejecting the donor's stem cells. The donated stem cells may replace the patient's immune system and help destroy any remaining abnormal cells. Sometimes the transplanted cells from a donor can also make an immune response against the body's normal cells. Giving anti-thymocyte globulin before and methotrexate and cyclosporine after transplant may stop this from happening

Aplastic Anemia

Fred Hutchinson Cancer Center21 participantsStarted Feb 2006

Salt Lake City, Utah, United States • Seattle, Washington, United States • Milwaukee, Wisconsin, United States

Maternal Immunization: Giving Immunity For Tomorrow

Immunization Protection in Child Care (IPiCC) Project

Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant

Find Trials by Condition in Salt Lake City

Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg

BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study

Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS

Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Salivary Diagnostic Testing for IVF

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

Depression in Alzheimer's Disease-2

Safety and Efficacy of Cariprazine for Bipolar I Disorder

Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer